1 Study Coverage 1.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Introduction 1.2 Market by Type 1.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Growth Rate by Type 1.2.2 Acalabrutinib 1.2.3 Zanubrutinib 1.2.4 Ibrutinib 1.3 Market by Application 1.3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Growth Rate by Application 1.3.2 Tumor 1.3.3 Autoimmunity 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size, Estimates and Forecasts 2.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue 2016-2027 2.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales 2016-2027 2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Historical Market Size by Region (2016-2021) 2.3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Region (2022-2027) 2.4.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Region (2022-2027) 3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Competitor Landscape by Players 3.1 Global Top Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturers by Sales 3.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Manufacturer (2016-2021) 3.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturers by Revenue 3.2.1 Key Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturers Covered: Ranking by Revenue 3.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Manufacturers (2016-2021) 3.2.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue in 2020 3.2.6 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Manufacturers 3.4 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base Distribution, Product Types 3.4.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Type 3.4.3 Date of International Manufacturers Enter into Bruton’s Tyrosine Kinase (BTK) Inhibitor Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Type (2016-2021) 4.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2021) 4.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2016-2021) 4.1.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Forecast by Type (2022-2027) 4.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Type (2022-2027) 4.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Type (2022-2027) 4.2.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Application (2016-2021) 5.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2021) 5.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2016-2021) 5.1.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Application (2016-2021) 5.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Forecast by Application (2022-2027) 5.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Application (2022-2027) 5.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Application (2022-2027) 5.2.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size YoY Growth 2016-2027 6.1.1 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales YoY Growth 2016-2027 6.1.2 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue YoY Growth 2016-2027 6.1.3 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share in Global Market 2016-2027 6.2 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Players (International and Local Players) 6.2.1 China Top Bruton’s Tyrosine Kinase (BTK) Inhibitor Players by Sales (2016-2021) 6.2.2 China Top Bruton’s Tyrosine Kinase (BTK) Inhibitor Players by Revenue (2016-2021) 6.3 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Historic Market Review by Type (2016-2021) 6.3.1 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2016-2021) 6.3.2 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2016-2021) 6.3.3 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Type (2016-2021) 6.4 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Type (2022-2027) 6.4.2 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Type (2022-2027) 6.4.3 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Price Forecast by Type (2022-2027) 6.5 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Historic Market Review by Application (2016-2021) 6.5.1 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2016-2021) 6.5.2 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2016-2021) 6.5.3 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Application (2016-2021) 6.6 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Application (2022-2027) 6.6.2 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Application (2022-2027) 6.6.3 China Bruton’s Tyrosine Kinase (BTK) Inhibitor Price Forecast by Application (2022-2027) 7 North America 7.1 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size YoY Growth 2016-2027 7.2 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country 7.2.1 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021) 7.2.2 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size YoY Growth 2016-2027 8.2 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Region 8.2.1 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2016-2021) 8.2.2 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size YoY Growth 2016-2027 9.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country 9.2.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021) 9.2.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size YoY Growth 2016-2027 10.2 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country 10.2.1 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021) 10.2.2 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country 11.2.1 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021) 11.2.2 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 AbbVie 12.1.1 AbbVie Corporation Information 12.1.2 AbbVie Description and Business Overview 12.1.3 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.1.4 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.1.5 AbbVie Recent Development 12.2 Johnson & Johnson 12.2.1 Johnson & Johnson Corporation Information 12.2.2 Johnson & Johnson Description and Business Overview 12.2.3 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.2.5 Johnson & Johnson Recent Development 12.3 Principia Biopharma 12.3.1 Principia Biopharma Corporation Information 12.3.2 Principia Biopharma Description and Business Overview 12.3.3 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.3.5 Principia Biopharma Recent Development 12.4 Merck 12.4.1 Merck Corporation Information 12.4.2 Merck Description and Business Overview 12.4.3 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.4.5 Merck Recent Development 12.5 Sunesis Pharmaceuticals 12.5.1 Sunesis Pharmaceuticals Corporation Information 12.5.2 Sunesis Pharmaceuticals Description and Business Overview 12.5.3 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.5.5 Sunesis Pharmaceuticals Recent Development 12.6 BeiGene 12.6.1 BeiGene Corporation Information 12.6.2 BeiGene Description and Business Overview 12.6.3 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.6.4 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.6.5 BeiGene Recent Development 12.7 Novartis 12.7.1 Novartis Corporation Information 12.7.2 Novartis Description and Business Overview 12.7.3 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.7.5 Novartis Recent Development 12.8 Sanofi 12.8.1 Sanofi Corporation Information 12.8.2 Sanofi Description and Business Overview 12.8.3 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.8.5 Sanofi Recent Development 12.9 Celgene Corporation 12.9.1 Celgene Corporation Corporation Information 12.9.2 Celgene Corporation Description and Business Overview 12.9.3 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.9.5 Celgene Corporation Recent Development 12.10 Loxo 12.10.1 Loxo Corporation Information 12.10.2 Loxo Description and Business Overview 12.10.3 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.10.5 Loxo Recent Development 12.11 AbbVie 12.11.1 AbbVie Corporation Information 12.11.2 AbbVie Description and Business Overview 12.11.3 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.11.4 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered 12.11.5 AbbVie Recent Development 12.12 Hengrui 12.12.1 Hengrui Corporation Information 12.12.2 Hengrui Description and Business Overview 12.12.3 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Hengrui Products Offered 12.12.5 Hengrui Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Industry Trends 13.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Drivers 13.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Challenges 13.4 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Acalabrutinib Table 3. Major Manufacturers of Zanubrutinib Table 4. Major Manufacturers of Ibrutinib Table 5. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Regions (2016-2021) & (K Units) Table 8. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Regions (2016-2021) Table 9. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share Forecast by Region (2022-2027) Table 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturers by Revenue (US$ Million) in 2020 Table 17. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Manufacturers (2016-2021) Table 19. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bruton’s Tyrosine Kinase (BTK) Inhibitor as of 2020) Table 21. Key Manufacturers Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (2016-2021) (US$/Unit) Table 22. Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Type Table 24. Date of International Manufacturers Enter into Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2021) (K Units) Table 27. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Type (2016-2021) Table 28. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2016-2021) (US$ Million) Table 29. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Type (2016-2021) Table 30. Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share Forecast by Type (2022-2027) Table 33. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2021) (K Units) Table 37. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Application (2016-2021) Table 38. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2016-2021) (US$ Million) Table 39. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Application (2016-2021) Table 40. Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share Forecast by Application (2022-2027) Table 43. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) of Key Companies (2016-2021) Table 47. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Company (2016-2021) Table 48. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Company (2016-2021) Table 49. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Company (2016-2021) Table 50. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Type (2016-2021) Table 51. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Type (2016-2021) Table 52. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2016-2021) Table 54. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Type (2022-2027) Table 55. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Type (2022-2027) Table 56. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Type (2022-2027) Table 58. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2022-2027) Table 59. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Application (2016-2021) Table 60. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Application (2016-2021) Table 61. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2016-2021) Table 63. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Application (2022-2027) Table 64. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Application (2022-2027) Table 65. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Application (2022-2027) Table 67. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2022-2027) Table 68. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021) & (K Units) Table 69. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2016-2021) Table 70. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2016-2021) Table 76. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021) & (K Units) Table 77. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2016-2021) Table 78. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2016-2021) Table 80. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021) & (K Units) Table 81. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2016-2021) Table 88. AbbVie Corporation Information Table 89. AbbVie Description and Business Overview Table 90. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Table 92. AbbVie Recent Development Table 93. Johnson & Johnson Corporation Information Table 94. Johnson & Johnson Description and Business Overview Table 95. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Johnson & Johnson Product Table 97. Johnson & Johnson Recent Development Table 98. Principia Biopharma Corporation Information Table 99. Principia Biopharma Description and Business Overview Table 100. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Principia Biopharma Product Table 102. Principia Biopharma Recent Development Table 103. Merck Corporation Information Table 104. Merck Description and Business Overview Table 105. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Merck Product Table 107. Merck Recent Development Table 108. Sunesis Pharmaceuticals Corporation Information Table 109. Sunesis Pharmaceuticals Description and Business Overview Table 110. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Sunesis Pharmaceuticals Product Table 112. Sunesis Pharmaceuticals Recent Development Table 113. BeiGene Corporation Information Table 114. BeiGene Description and Business Overview Table 115. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. BeiGene Product Table 117. BeiGene Recent Development Table 118. Novartis Corporation Information Table 119. Novartis Description and Business Overview Table 120. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Novartis Product Table 122. Novartis Recent Development Table 123. Sanofi Corporation Information Table 124. Sanofi Description and Business Overview Table 125. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. Sanofi Product Table 127. Sanofi Recent Development Table 128. Celgene Corporation Corporation Information Table 129. Celgene Corporation Description and Business Overview Table 130. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Celgene Corporation Product Table 132. Celgene Corporation Recent Development Table 133. Loxo Corporation Information Table 134. Loxo Description and Business Overview Table 135. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. Loxo Product Table 137. Loxo Recent Development Table 138. ArQule Corporation Information Table 139. ArQule Description and Business Overview Table 140. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 141. ArQule Product Table 142. ArQule Recent Development Table 143. Hengrui Corporation Information Table 144. Hengrui Description and Business Overview Table 145. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 146. Hengrui Product Table 147. Hengrui Recent Development Table 148. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Trends Table 149. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Drivers Table 150. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Challenges Table 151. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Restraints Table 152. Bruton’s Tyrosine Kinase (BTK) Inhibitor Customers List Table 153. Bruton’s Tyrosine Kinase (BTK) Inhibitor Distributors List Table 154. Research Programs/Design for This Report Table 155. Key Data Information from Secondary Sources Table 156. Key Data Information from Primary Sources List of Figures Figure 1. Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Picture Figure 2. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type in 2020 & 2027 Figure 3. Acalabrutinib Product Picture Figure 4. Zanubrutinib Product Picture Figure 5. Ibrutinib Product Picture Figure 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application in 2020 & 2027 Figure 7. Tumor Figure 8. Autoimmunity Figure 9. Bruton’s Tyrosine Kinase (BTK) Inhibitor Report Years Considered Figure 10. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size 2016-2027 (US$ Million) Figure 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales 2016-2027 (K Units) Figure 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2016-2021) Figure 15. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region in 2020 Figure 16. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2016-2021) Figure 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region in 2020 Figure 18. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue in 2020 Figure 20. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2016-2021) Figure 22. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type in 2020 Figure 23. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2016-2021) Figure 24. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type in 2020 Figure 25. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2016-2021) Figure 26. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application in 2020 Figure 27. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2016-2021) Figure 28. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application in 2020 Figure 29. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate 2016-2027 (K Units) Figure 30. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share in Global Market 2016-2027 Figure 32. China 5 and 10 Largest Bruton’s Tyrosine Kinase (BTK) Inhibitor Players Market Share by Revenue in Bruton’s Tyrosine Kinase (BTK) Inhibitor in 2020 Figure 33. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Type (2016-2021) Figure 34. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate by Type in 2016 & 2020 Figure 35. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Application (2016-2021) Figure 36. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate 2016-2021 (K Units) Figure 38. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country in 2020 Figure 40. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country in 2020 Figure 41. U.S. Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 42. U.S. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 44. Canada Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate 2016-2021 (K Units) Figure 46. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country in 2020 Figure 48. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country in 2020 Figure 49. Germany Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 50. Germany Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 52. France Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 54. U.K. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 56. Italy Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 58. Russia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate 2016-2021 (K Units) Figure 60. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region in 2020 Figure 62. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region in 2020 Figure 63. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 64. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 66. Japan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 68. South Korea Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 70. India Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 72. Australia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 74. Taiwan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 76. Indonesia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 78. Thailand Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 80. Malaysia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 82. Philippines Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 84. Vietnam Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate 2016-2021 (K Units) Figure 86. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country in 2020 Figure 88. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country in 2020 Figure 89. Mexico Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 90. Mexico Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 92. Brazil Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 94. Argentina Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate 2016-2021 (K Units) Figure 96. Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country in 2020 Figure 99. Turkey Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 100. Turkey Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 102. Saudi Arabia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. UAE Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate (2016-2021) (K Units) Figure 104. UAE Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Bruton’s Tyrosine Kinase (BTK) Inhibitor Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

AbbVie Johnson & Johnson Principia Biopharma Merck Sunesis Pharmaceuticals BeiGene Novartis Sanofi Celgene Corporation Loxo ArQule Hengrui